At-Home STD Testing in 2026: What the New FDA-Authorized 30-Minute PCR Tests Can (and Can't) Treat Online
The FDA granted marketing authorization to Visby Medical’s at-home PCR test in March 2025, allowing people to test for chlamydia, gonorrhea, and trichomoniasis in about 30 minutes without a lab visit or prescription. If your result is positive, a telehealth provider can prescribe treatment for most bacterial STIs the same day—though gonorrhea now requires an injectable antibiotic that generally must be administered in person. Here’s what’s actually changed, what works at home, and where in-person care remains essential.
How long does an at-home chlamydia test take?
The Visby Medical Women’s Sexual Health Test—the first FDA-authorized over-the-counter PCR diagnostic for chlamydia, gonorrhea, and trichomoniasis—delivers results in approximately 30 minutes. You collect a self-obtained vaginal swab, insert it into a single-use powered testing device, and the companion app walks you through the steps and displays your results.
This is a meaningful shift from the previous standard: at-home STI collection kits (such as those from Everlywell or LetsGetChecked) required users to mail their sample to a certified laboratory and wait two to five days for results. The Visby device performs the PCR analysis locally, on the device itself, so no sample ever leaves your home.
What exactly is the Visby Medical PCR test?
Polymerase chain reaction (PCR) is the gold-standard method used in clinical labs to detect bacterial and viral DNA. Until now, PCR required specialized equipment found only in clinical or certified laboratory settings. Visby Medical miniaturized the PCR process into a single-use cartridge roughly the size of a stapler.
The FDA press announcement confirmed the test detects:
- Chlamydia trachomatis (CT)
- Neisseria gonorrhoeae (NG)
- Trichomonas vaginalis (TV)
The test is currently validated and authorized for people with female anatomy. A urine-based version for people with male anatomy has been submitted to the FDA by OraSure Technologies (as of late 2025) and is pending clearance.
How accurate is the at-home PCR test compared to a lab test?
In the clinical studies reviewed by the FDA, the Visby test performed comparably to laboratory-based NAAT (nucleic acid amplification test) methods—the current reference standard. Reported accuracy from the FDA authorization data:
| Pathogen | Sensitivity (detecting positives) | Specificity (detecting negatives) |
|---|---|---|
| Chlamydia trachomatis | 97.2% | 98.8% |
| Neisseria gonorrhoeae | 100% | 99.1% |
| Trichomonas vaginalis | 97.8% | 98.5% |
For comparison, lab-based PCR tests typically achieve 95–99% sensitivity and 99–100% specificity, per CDC guidance on STI laboratory testing. The at-home device’s performance falls solidly within that clinical range.
Which STIs can be treated online after a positive result?
Not all positive results lead to the same care pathway. This is the critical limitation the new tests don’t change: testing at home is now fast and accurate, but treatment still depends on the specific infection and your state’s telehealth prescribing rules.
| STI | Telehealth Rx? | Standard Treatment | Notes |
|---|---|---|---|
| Chlamydia | Yes | Doxycycline 100 mg × 7 days (CDC preferred 2026) | Safe to prescribe remotely; oral medication |
| Trichomoniasis | Yes | Metronidazole 2 g single dose | Oral; telehealth prescribing widely available |
| Gonorrhea | Usually no | Ceftriaxone 500 mg IM injection | Injectable; typically requires in-person visit |
| Syphilis | No | Benzathine penicillin G IM injection | In-person only; lab confirmation required |
| Herpes (HSV) | Yes | Valacyclovir (episodic or suppressive) | Telehealth appropriate for management |
| HIV | No | Requires confirmatory testing + specialist | PrEP/PEP initiation may be telehealth-eligible |
The CDC’s 2025 STI Treatment Guidelines updated first-line gonorrhea treatment to ceftriaxone 500 mg IM (intramuscular), which cannot be self-administered or prescribed remotely for home delivery in most cases. If your at-home test returns positive for gonorrhea, a telehealth provider can confirm the result, counsel you, notify you of recommended next steps, and refer you to an in-person clinic—but the treatment injection itself requires a clinic or urgent care visit.
Chlamydia and trichomoniasis, by contrast, are ideal candidates for telehealth care. According to CDC data, chlamydia remains the most commonly reported bacterial STI in the United States, with more than 1.5 million cases reported in 2024, making rapid, convenient treatment access a genuine public health benefit.
Which STIs still require an in-person visit?
Beyond gonorrhea’s injectable treatment requirement, several scenarios always warrant in-person evaluation:
- Pelvic inflammatory disease (PID): If you have chlamydia or gonorrhea with lower abdominal pain, fever, or cervical motion tenderness, PID is a medical urgency requiring in-person assessment and sometimes IV antibiotics.
- Syphilis: Requires a blood test (RPR/VDRL + confirmatory treponemal test) that goes beyond the scope of the current Visby device, plus injectable penicillin.
- HIV: A positive rapid HIV test requires confirmatory Western blot and immediate linkage to HIV care.
- Symptoms suggesting complications: Discharge with blood, severe pelvic pain, or testicular pain are not appropriate for home management.
When in doubt, contact a provider first before deciding which pathway is appropriate.
How does the telehealth treatment process work after a positive at-home test?
If your Visby result is positive for chlamydia or trichomoniasis, the app connects you with healthcare options—including telehealth services. Providers can review your result, intake questionnaire, allergies, and any current medications, then send a prescription to your local pharmacy within hours.
The typical flow:
- Test at home, receive result in ~30 minutes
- Open the app → connect with a telehealth provider (or use a separate telehealth service)
- Provider reviews result + brief medical history
- Prescription sent to pharmacy or via mail-order
- Partner notification counseling provided
Most major telehealth platforms can process chlamydia and trichomoniasis prescriptions 24/7. Under the telehealth prescribing expansions that remain in effect through December 31, 2026, providers in most states can prescribe these treatments via asynchronous (message-based) visits, meaning you don’t even need a live video call.
Is the at-home STI test available without a prescription?
Yes. The FDA’s marketing authorization designates the Visby Women’s Sexual Health Test as an over-the-counter (OTC) product—no prescription required to purchase or use it. As of early 2026, Visby has partnered with Quest Diagnostics and LabCorp distribution networks to broaden retail and online availability.
The LetsGetChecked Simple 2 system (FDA-cleared in December 2025) also allows at-home vaginal swab or urine collection for chlamydia and gonorrhea, though it uses a mail-in lab model rather than on-device PCR—so results take one to three business days rather than 30 minutes.
What should I do about partner notification?
A positive result carries a partner notification responsibility regardless of how you tested. Most state health departments offer free, confidential partner notification services. Some telehealth providers also offer anonymous partner notification through services like doxy.me or the CDC’s partner services programs. Prompt partner notification helps break transmission chains and ensures your partner receives treatment before potential re-exposure occurs.
The CDC STI treatment guidelines recommend treating partners empirically (without waiting for their own test results) when chlamydia or gonorrhea is confirmed—a practice called expedited partner therapy (EPT), which is legal in most US states.
When should you test?
The CDC recommends annual chlamydia and gonorrhea screening for:
- All sexually active women younger than 25
- Women 25 and older with new or multiple partners
- Men who have sex with men (MSM): every 3–6 months if sexually active
- Anyone with new or multiple partners, or whose partner has an STI
If you have symptoms—unusual discharge, burning with urination, sores, or pelvic discomfort—don’t wait for a scheduled screening. Test now.
Our STI and STD testing and treatment service connects you with a licensed provider who can evaluate your symptoms, review at-home test results, and send prescriptions for treatable infections to your pharmacy the same day.
Frequently Asked Questions
Can a telehealth doctor treat a positive chlamydia result without me coming in? Yes. Chlamydia is treated with oral antibiotics (doxycycline or azithromycin) that can be prescribed remotely and filled at any pharmacy. You don’t need an in-person visit unless you have symptoms suggesting complications like pelvic inflammatory disease.
Is the 30-minute at-home PCR test as accurate as a lab test? Clinical data submitted to the FDA shows the Visby test achieves sensitivity and specificity of 97–100% for chlamydia, gonorrhea, and trichomoniasis—comparable to laboratory NAAT tests, which are the current clinical gold standard.
What if my at-home test is positive for gonorrhea? Contact a telehealth provider or clinic promptly. The current CDC-recommended treatment—ceftriaxone 500 mg by intramuscular injection—must be administered in person. A telehealth provider can guide you to the appropriate in-person resource and ensure partner notification.
Can men use the Visby at-home PCR test? The current FDA-authorized version is validated for vaginal swab collection and intended for people with female anatomy. Urine-based tests for male anatomy are under FDA review (OraSure Technologies submission, late 2025) but not yet authorized as of mid-2026.
Will insurance cover an at-home STI PCR test? Coverage varies by plan. Under the ACA, most insurance plans must cover FDA-approved STI screenings for recommended populations without cost-sharing when ordered by a provider. OTC at-home tests purchased without a prescription may not be reimbursed under all plans—check with your insurer. HSA and FSA funds generally can be used.
Ready to take the next step? If you’ve received a positive at-home result or have symptoms you’re concerned about, our providers are available now. Schedule a confidential visit with Omnia TeleHealth and get answers—and a prescription if appropriate—without a waiting room.